Welcome

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

News

03/27/2025 | Aromics joins the BME Pre-Market Environment
Aromics, has been incorporated into the Pre-Market Environment (EpM) of Bolsas... More

03/14/2025 | Aromics at NextGen Biomed 2025
Our CMO, Dr. Sonia Macia was one of the speakers at the NextGen Biomed ... More